Education
About Us
Working with TipRanks
Follow Us
Edwards Lifesciences (EW)
NYSE:EW
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.44B | $ 6.00B | $ 5.38B | $ 5.23B | $ 4.39B |
| Gross Profit | $ 4.32B | $ 4.63B | $ 4.30B | $ 3.98B | $ 3.31B |
| Operating Income | $ 1.38B | $ 1.53B | $ 1.75B | $ 1.35B | $ 1.63B |
| EBITDA | $ 1.72B | $ 1.77B | $ 1.96B | $ 1.89B | $ 1.07B |
| Net Income | $ 4.17B | $ 1.40B | $ 1.52B | $ 1.50B | $ 823.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.98B | $ 1.64B | $ 1.22B | $ 1.47B | $ 1.40B |
| Total Assets | $ 13.06B | $ 9.36B | $ 8.29B | $ 8.50B | $ 7.24B |
| Total Debt | $ 700.00M | $ 694.90M | $ 691.30M | $ 690.30M | $ 694.90M |
| Net Debt | $ -2.35B | $ -449.10M | $ -77.70M | $ -172.50M | $ -488.30M |
| Total Liabilities | $ 2.99B | $ 2.64B | $ 2.49B | $ 2.67B | $ 2.66B |
| Stockholders' Equity | $ 10.00B | $ 6.65B | $ 5.81B | $ 5.84B | $ 4.57B |
| Cash Flow | |||||
| Free Cash Flow | $ 289.90M | $ 629.50M | $ 953.40M | $ 1.40B | $ 647.00M |
| Operating Cash Flow | $ 542.30M | $ 895.80M | $ 1.22B | $ 1.73B | $ 1.05B |
| Investing Cash Flow | $ 2.31B | $ 173.80M | $ 252.30M | $ -1.72B | $ -531.10M |
| Financing Cash Flow | $ -983.00M | $ -711.00M | $ -1.58B | $ -356.30M | $ -486.90M |